The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients

The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients

<p>Abstract</p> <p>Background</p> <p>The effect of thiopurine immunomodulators on health-related quality of life (HRQoL) in patients with inflammatory bowel disease (IBD) has been controversial. The aims were to evaluate the HRQoL in patients with IBD treated with thiop...

Full description

Bibliographic Details
Main Authors:	Beltrán Belén, Aguas Mariam, Nos Pilar, Bastida Guillermo, Iborra Marisa, Ortiz Vicente, Garrigues Vicente, Estevan Rafael, Ponce Julio
Format:	Article
Language:	English
Published:	BMC 2010-03-01
Series:	BMC Gastroenterology
Online Access:	http://www.biomedcentral.com/1471-230X/10/26

Similar Items

Optimising thiopurine therapy in inflammatory bowel disease
by: Wong, L. H. J.
Published: (2005)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
by: Carla J. Gargallo-Puyuelo, et al.
Published: (2021-07-01)

Laboratory determination of thiopurine levels in paediatric patients with inflammatory bowel disease
by: Rafael Martín-Masot, et al.
Published: (2020-07-01)

Mercaptopurine and inflammatory bowel disease: the other thiopurine
by: Fernando Bermejo, et al.

Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease
by: Jack S. Cornish, et al.
Published: (2020-01-01)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
by: Keiichi Tominaga, et al.
Published: (2021-01-01)

The Utility of Thiopurine Methyltransferase Enzyme Testing in Inflammatory Bowel Disease
by: Laura Chisick, et al.
Published: (2013-01-01)

Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease
by: Esteban Sáez-González, et al.
Published: (2019-05-01)

Septic thrombophlebitis of the superior mesenteric vein and multiple liver abscesses in a patient with Crohn's disease at onset
by: Grueso Jose, et al.
Published: (2007-06-01)

gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
by: Katsuyoshi Matsuoka
Published: (2020-07-01)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
by: Raphael P. Luber, et al.
Published: (2019-11-01)

Interindividual differences in thiopurine metabolism : studies with focus on inflammatory bowel disease
by: Haglund, Sofie
Published: (2011)

Prescribing trends and the impact of thiopurines on the risk of surgery in inflammatory bowel disease
by: Chhaya, Vivek Haresh
Published: (2016)

Idiopathic portal hypertension regarding thiopurine treatment in patients with inflammatory bowel disease
by: Cristina Suárez-Ferrer, et al.
Published: (2016-02-01)

In Vivo Genotoxicity and Selection Associated with Thiopurine Treatment in Subjects with Inflammatory Bowel Disease
by: Nguyen, Truc
Published: (2008)

Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients
by: Liang Ding, et al.
Published: (2021-05-01)

Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
by: Yue-Ping Liu, et al.
Published: (2015-01-01)

Epstein-Barr Virus Infection and Thiopurine Therapy in a Pediatric Population with Inflammatory Bowel Disease
by: Maria Do Céu Espinheira, et al.
Published: (2020-04-01)

Thiopurine -methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
by: Polina Zalizko, et al.
Published: (2020-07-01)

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
by: Davide Giuseppe Ribaldone, et al.
Published: (2019-08-01)

Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.
by: Jianfeng Gong, et al.
Published: (2013-01-01)

Canadian Association of Gastroenterology Position Statement Regarding the Use of Thiopurines for the Treatment of Inflammatory Bowel Disease
by: John K Marshall, et al.
Published: (2014-01-01)

Usefulness of Measuring Thiopurine Metabolites in Children with Inflammatory Bowel Disease and Autoimmunological Hepatitis, Treated with Azathioprine
by: Katarzyna Bąk-Drabik, et al.
Published: (2021-01-01)

A search for novel biomarkers predicting toxicity and response to thiopurine treatment in patients with inflammatory bowel disease
by: Blaker, Paul Andrew
Published: (2014)

Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus Groups
by: Javier Del Hoyo, et al.
Published: (2020-03-01)

Pharmacogenetic studies of thiopurines : focus on thiopurine methyltransferase
by: Lindqvist Appell, Malin
Published: (2005)

Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?
by: Sofie Haglund, et al.
Published: (2013-01-01)

Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
by: Sheng Zhang Lim, et al.
Published: (2018-10-01)

Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
by: Abaji R, et al.
Published: (2017-05-01)

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)
by: Kang-Moon Lee, et al.
Published: (2015-07-01)

Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients
by: Pedro López-Muñoz, et al.
Published: (2019-05-01)

A Practical Non-Extraction Direct Liquid Chromatography Method for Determination of Thiopurine S-Methyltransferase Activity in Inflammatory Bowel Disease
by: Fariborz Bahrehmand, et al.
Published: (2017-08-01)

NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
by: Toshiyuki Sato, et al.
Published: (2017-07-01)

Thiopurine Methyltransferase Enzyme Activity Determination before Treatment of Inflammatory Bowel Disease with Azathioprine: Effect on Cost and Adverse Events
by: Farzana A Sayani, et al.
Published: (2005-01-01)

TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India
by: Narinder Grover, et al.
Published: (2021-08-01)

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan
by: Shunsuke Komoto, et al.
Published: (2016-04-01)

Risk of malignancies in patients with inflammatory bowel disease who used thiopurines as compared with other indications: a territory-wide study
by: Kelvin Y. C. Zheng, et al.
Published: (2020-11-01)

A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
by: Shunichi Odahara, et al.
Published: (2015-01-01)

Analytical and Sample Preparation Protocol for Therapeutic Drug Monitoring of 12 Thiopurine Metabolites Related to Clinical Treatment of Inflammatory Bowel Disease
by: Daniel Pecher, et al.
Published: (2018-07-01)

The cellular pharmacology of thiopurine drugs
by: Little, Margaret
Published: (2004)